How to Use Setmelanotide
Complete guide to Setmelanotide dosing, administration, timing, and protocol recommendations.
Quick Overview
Setmelanotide (brand name Imcivree) is a melanocortin-4 receptor (MC4R) agonist peptide and a genuine FDA-approved obesity drug, first cleared in 2020. It is not a general weight-loss shot like the GLP-1 drugs: it is a targeted therapy for rare genetic forms of severe obesity where a specific brain hunger circuit is broken. It is given as a once-daily subcutaneous injection and has since been approved for additional conditions including Bardet-Biedl syndrome and acquired hypothalamic obesity.
Dosing Guidelines
Common Dose
2-3 mg daily
Frequency
Once daily
Dose Range
1-3 mg daily
Note: FDA-approved for specific genetic obesities (POMC, PCSK1, LEPR deficiency). Prescription only.
Administration Method
Subcutaneous injection daily
Best Time to Take
Before bed or morning (fasted)
GH-related peptides work best on an empty stomach to maximize growth hormone release.
Protocol Duration
Long-term / chronic use
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Skin hyperpigmentation (67-83%)
- •Injection site reactions
- •Nausea
- •Spontaneous erections in males
- •Priapism risk
Frequently Asked Questions
What is the recommended dose for Setmelanotide?
2-3 mg daily
How do you administer Setmelanotide?
Subcutaneous injection daily
When is the best time to take Setmelanotide?
Before bed or morning (fasted)
How long should you use Setmelanotide?
Long-term / chronic use
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.